Olaparib monotherapy for BRIP1-mutated high-grade serous endometrial cancer

Kohei Nakamura, Eriko Aimono, Shigeki Tanishima, Mitsuho Imai, Akiko Kawano Nagatsuma, Hideyuki Hayashi, Yuki Yoshimura, Kentaro Nakayama, Satoru Kyo, Hiroshi Nishihara

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)283-290
Number of pages8
JournalJCO Precision Oncology
Volume3
DOIs
Publication statusPublished - 2019 Jan 1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Nakamura, K., Aimono, E., Tanishima, S., Imai, M., Nagatsuma, A. K., Hayashi, H., Yoshimura, Y., Nakayama, K., Kyo, S., & Nishihara, H. (2019). Olaparib monotherapy for BRIP1-mutated high-grade serous endometrial cancer. JCO Precision Oncology, 3, 283-290. https://doi.org/10.1200/PO.19.00368